Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516256 · ClinicalTrials.gov registry record · NA
CHESS: Human and Computer Mentors for Prostate Cancer Patients
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00516256: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00516256 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 209 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00516256, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL). * CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL * CHESS +Cancer Information Mentor will have the largest impact on QOL (initially and late in treatment) and will be significantly better than either CHESS or Cancer Information Mentor alone. 2. To measure potential intervening or mediating processes, so that we can determine how CHESS and the Cancer Information Mentor produce associated QOL benefits. 3. To conduct exploratory use analyses examining which types of CHESS content, sequential patterns of content use, or other characteristics of use behavior are associated with greater pretest-posttest improvements in QOL. 4. To conduct a secondary analysis exploring whether men whose partners have actively used CHESS do better than those whose partners did not use CHESS.
Interventions
- BEHAVIORAL CHESS System
- BEHAVIORAL Cancer Information Mentor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2007-07-03 |
| Est. Completion | 2018-05-11 |
| Phase | NA |
What the finished NCT00516256 record still lists
NCT00516256 is an interventional study that assigns participants to a tested intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which CHESS System is the first listed.
NCT00516256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00516256 about?
NCT00516256 is a clinical study titled "CHESS: Human and Computer Mentors for Prostate Cancer Patients". The aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL). * CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL * CHESS +Cancer Information Mentor will have the largest impact on QOL (initiall...
What is the current status of trial NCT00516256?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2007-07-03. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT00516256?
The interventions under investigation include: CHESS System (BEHAVIORAL), Cancer Information Mentor (BEHAVIORAL).
Who is sponsoring clinical trial NCT00516256?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00516256's enrollment target sits among peer trials
209 496th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI